Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: SciBase Holding AB

Market Cap 500M 53.27M 45.91M 42.25M 39.64M 74.46M 5.03B 75.2M 195M 2.47B 200M 196M 8.53B P/E Ratio 2026 *
-
P/E Ratio 2027 * -
Enterprise Value 500M 53.27M 45.91M 42.25M 39.64M 74.46M 5.03B 75.2M 195M 2.47B 200M 196M 8.53B EV / Sales 2026 *
7.58x
EV / Sales 2027 * 4.79x
Free-Float
77.17%
Yield 2026 *
-
Yield 2027 * -
1 day-2.30%
1 week-0.31%
Current month+5.28%
1 month+2.41%
3 months+69.62%
6 months+43.68%
Current year+41.59%
1 week 46.35
Extreme 46.35
52.7
1 month 37.5
Extreme 37.5
54
Current year 18.5
Extreme 18.5
54
1 year 18.5
Extreme 18.5
54
3 years 18.5
Extreme 18.5
148.4
5 years 18.5
Extreme 18.5
657
10 years 18.5
Extreme 18.5
3,020
Manager TitleAgeSince
Chief Executive Officer 59 01/10/2023
Director of Finance/CFO 64 01/01/2014
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member 60 16/05/2017
Chairman 65 13/06/2024
Director/Board Member 68 -
Change 5-day change 1-year change 3-year change Capi.($)
-2.30%-0.31%+29.23%-58.53% 53.27M
+2.10%-1.32%+8.69%-34.57% 16.44B
+1.62%+6.75%+32.09%+63.86% 1.69B
+0.75%-2.66%-29.98%+18.35% 1.12B
+3.11%+0.73%-49.58%-83.13% 994M
-0.82%-0.37%-22.18%-53.91% 644M
-0.94%-1.25%-46.24%-57.20% 564M
-5.43%+1.46%+27.47%-54.57% 440M
+0.78%-0.62%-54.52%-62.17% 394M
-1.16%+15.85%-23.77%-20.28% 373M
Average -0.22%+1.91%-12.88%-34.22% 2.27B
Weighted average by Cap. +1.70%-2.67%+2.53%-28.57%

Financials

2026 *2027 *
Net sales 65.9M 7.03M 6.06M 5.57M 5.23M 9.82M 664M 9.92M 25.74M 325M 26.37M 25.81M 1.13B 104M 11.11M 9.58M 8.81M 8.27M 15.53M 1.05B 15.69M 40.7M 514M 41.7M 40.81M 1.78B
Net income -66.3M -7.07M -6.09M -5.61M -5.26M -9.88M -668M -9.98M -25.9M -327M -26.53M -25.97M -1.13B -51.5M -5.49M -4.73M -4.36M -4.09M -7.68M -519M -7.75M -20.12M -254M -20.61M -20.17M -879M
Net Debt - -
Logo SciBase Holding AB
SciBase Holding AB (publ) is a Sweden-based company engaged in the medical equipment industry. The Company specializes in the manufacture of point of care device, called Nevisense, which is aimed to detect of malignant melanoma. Nevisense analyze suspicious lesions by using Electrical Impedance Spectroscopy (EIS) which is applied as an electrical signal to the skin. SciBase Holding AB (publ) specializes in early detection and prevention in dermatology. The Company develops and commercializes Nevisense, a point-of-care platform that combines AI (artificial intelligence) and advanced EIS technology to elevate diagnostic accuracy, ensuring proactive skin health management. SciBase Holding AB (publ) combines advanced EIS technology with AI to empower healthcare professionals by improving diagnostic precision, facilitating disease monitoring, and enabling early detection of skin cancer.
Employees
49
Date Price Change Volume
15/06/26 48.85 kr -2.30% 5,335
12/06/26 50.00 kr -1.57% 5,943
11/06/26 50.80 kr +1.60% 2,799
10/06/26 50.00 kr +1.63% 8,492
09/06/26 49.20 kr +0.41% 30,687

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. SCIB Stock
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!